Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
City of Hope Medical Center
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University of Texas Southwestern Medical Center
Roswell Park Cancer Institute
Stanford University
Alliance for Clinical Trials in Oncology
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Virginia Commonwealth University
Wake Forest University Health Sciences
University of California, Davis
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
The Cleveland Clinic
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Yale University
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
City of Hope Medical Center
Mesoblast, Ltd.
City of Hope Medical Center
Columbia University
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northside Hospital, Inc.
University of California, San Francisco